In our July edition of CVS Caremark Insights, we explore recent formulary updates aimed at expanding access to these high-demand therapies while improving affordability
For full safety details and prescribing information, please refer to: Ozempic Prescribing Information (FDA) Wegovy Prescribing Information (FDA) Rybelsus Prescribing Information (FDA) Data Last Updated 06/04/2026
an alternative funded GLP-1 receptor agonist As a result of global supply issues with dulaglutide, Pharmac funded an alternative GLP-1 receptor agonist, liraglutide, with Special Authority approval from March, 2023
Understanding how semaglutide makes you feel throughout the injection cycle helps you plan protein intake around your natural appetite patterns
Un aminocido es mejor tomarlo 1/2 hora antes de cualquier comida o antes de acostarse
A call to update anesthetic protocols: the hidden risks of semaglutide [PMID: 38807009] Laboratory literature summary: A call to update anesthetic protocols: the hidden risks of semaglutide